Yaqeen for cancer Technology


market access

R.G.C.C. Group was established in 2004 by Dr. Ioannis Papasotiriou. R.G.C.C. Group is a global organization working in collaboration with branch offices and distributors to provide a world-wide service.

Our collaborators are well established and our work together is prolific.

Al-Yaqeen for cancer technology was officially established in 2015 in Jordan by Prof. Dr. Luay Jamil Rashan PhD, D.Sc., N.D., FRSH. And Mr. Nashwan Hazim Al-Saoo (Businessman/Industrial Pharmaceutical) Representing R.G.C.C. international GmbH (Research Genetic Cancer Center) in 22 Arab countries and Iran.

Website: www.yaqeen-ct.com

The company is a pioneering, innovative organization working in the fields of medical genetics and, in particular, cancer genetics, chemosensitivity and chemo-resistance testing and in Research and Development within the pharmaceutical industry via R.G.C.C. Pharma Ltd The company headquarters are in Switzerland, and our brand new, state of the art laboratories in Northern Greece are equipped with the most up-to-date technologically advanced and innovative equipment.

The company primary concern is for the welfare of cancer patients seeking the very best personalized and integrated treatments and to ensure that clinicians have access to the most up-to-date information which can benefit their patients.

Website: www.rgcc-group.com